What is he best known for?
The fields of study he is best known for:
George F. Vande Woude mainly investigates Cancer research, Hepatocyte growth factor, Molecular biology, Tyrosine kinase and Receptor tyrosine kinase.
His biological study spans a wide range of topics, including Carcinogenesis, Cancer, Metastasis, Signal transduction and C-Met.
His Cancer study incorporates themes from c-Met inhibitor and Endocrinology.
George F. Vande Woude focuses mostly in the field of Signal transduction, narrowing it down to matters related to Receptor and, in some cases, In vivo.
His work carried out in the field of Hepatocyte growth factor brings together such families of science as Cell, Thrombospondin 1, STAT protein and Cell biology.
His Molecular biology study combines topics in areas such as Meiosis, RNA, Xenopus, Proto-Oncogene Proteins c-met and Kinase.
His most cited work include:
- Met, metastasis, motility and more (2154 citations)
- Targeting MET in cancer: rationale and progress (1002 citations)
- Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor (912 citations)
What are the main themes of his work throughout his whole career to date?
George F. Vande Woude spends much of his time researching Cancer research, Hepatocyte growth factor, Molecular biology, Cancer and Receptor tyrosine kinase.
His studies deal with areas such as Paracrine signalling, Tyrosine kinase, Signal transduction, Immunology and Metastasis as well as Cancer research.
The various areas that George F. Vande Woude examines in his Hepatocyte growth factor study include Autocrine signalling, Cell growth and Cell biology.
George F. Vande Woude interconnects Cell culture, Genetics, RNA, Xenopus and Proto-Oncogene Proteins c-met in the investigation of issues within Molecular biology.
His Cancer study combines topics from a wide range of disciplines, such as Lung cancer and Oncology.
His work deals with themes such as Carcinogenesis and Monoclonal antibody, which intersect with Receptor tyrosine kinase.
He most often published in these fields:
- Cancer research (43.68%)
- Hepatocyte growth factor (29.89%)
- Molecular biology (24.14%)
What were the highlights of his more recent work (between 2012-2019)?
- Cancer research (43.68%)
- Hepatocyte growth factor (29.89%)
- Receptor tyrosine kinase (20.11%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Hepatocyte growth factor, Receptor tyrosine kinase, Cancer and Signal transduction.
His Cancer research research is multidisciplinary, incorporating perspectives in Tyrosine kinase, Proto-oncogene tyrosine-protein kinase Src, Breast cancer, PI3K/AKT/mTOR pathway and Monoclonal antibody.
The concepts of his Hepatocyte growth factor study are interwoven with issues in Targeted therapy and Mechanism of action.
His studies in Receptor tyrosine kinase integrate themes in fields like Onartuzumab, Coiled coil, Binding site and MAPK/ERK pathway.
He is studying Cancer cell, which is a component of Cancer.
His study on Signal transduction also encompasses disciplines like
- Carcinogenesis that connect with fields like Cadherin, Proto-Oncogene Proteins c-met and Immunology,
- Phosphorylation most often made with reference to Mutation.
Between 2012 and 2019, his most popular works were:
- Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent (162 citations)
- MET: A Critical Player in Tumorigenesis and Therapeutic Target (80 citations)
- Chromosome instability drives phenotypic switching to metastasis. (34 citations)
In his most recent research, the most cited papers focused on:
George F. Vande Woude mainly focuses on Cancer research, Receptor tyrosine kinase, Hepatocyte growth factor, Signal transduction and Tyrosine kinase.
George F. Vande Woude has researched Cancer research in several fields, including Molecular biology, Targeted therapy and Hepatitis B virus.
His work on ERBB3 as part of general Receptor tyrosine kinase study is frequently linked to Context, bridging the gap between disciplines.
George F. Vande Woude combines subjects such as Hepatitis B, Cancer, Bioinformatics and Hepatitis with his study of Hepatocyte growth factor.
George F. Vande Woude has included themes like Cell growth, Erlotinib Hydrochloride, Erlotinib, EGFR inhibitors and Pharmacology in his Signal transduction study.
The study incorporates disciplines such as Protein kinase B, Gene knockdown, Breast cancer, PI3K/AKT/mTOR pathway and MAPK/ERK pathway in addition to Tyrosine kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
